Vitrolife Group (VITR) Nordic Small & Mid Cap Seminar Handelsbanken presentation summary

Market overview and opportunity

• Infertility affects 1 in 6 adults globally, representing a significant healthcare issue and market opportunity.

• Less than 1% of the 134 million babies born annually are conceived via IVF, with successful treatment outcomes around 33%.

• Estimated IVF cycle growth is around 5% in the coming years, constrained by access and affordability.

Key market dynamics

• Growing demand for IVF is driving the need for increased capacity and accessibility.

• Labor and skills shortages in clinics highlight the need for automation and digitalization.

• Market consolidation and regionalization require standardization and scalability.

• Patient empowerment and education are increasingly important.

Corporate strategy and objectives

• Vision is to enable people to fulfill the dream of having a healthy baby, with a mission to be the leading global partner in reproductive health.

• Targets include annual organic revenue growth over 10%, EBITDA margin above 33%, and net debt/EBITDA below 3.

• Strategic focus on innovation, operational excellence, and growth in key markets.